Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
INTERROGATE: Erenumab Pharmacogenetics in Migraine
NCT04265755Phase 4Completed
- Sponsor
- Amgen
- Start
- Oct 2020
- Primary completion
- Jan 2023
- Modality
- Monoclonal Antibodies
- Countries
- 2
01
Overview
A Phase 4 trial of erenumab in migraine, sponsored by Amgen. Started Oct 2020; status: completed.
02
Drugs
erenumab
03
Conditions
migraine
Beyond the preview
Go deeper on NCT04265755.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04265755.